Paul Ehrlich (1854-1915)

A Note From History. 2000 years of chemotherapy of tumors
 

Cancer 2005;103:1097

Near the end of the 17th century it was generally accepted that cancer started as a local lesion and grew by destroying surrounding tissues. With this in mind, more and more remedies were introduced to cure cancer before it became destructive. The most complete Materia Medica of the time, compiled by the druggist Pomet, listed all known remedies. This was followed in 1712 by an English publication of available recipes. Some of the highly recommended prescriptions were Tinctura vitriolata (two drops a day) and solution of alkali such as camphor, chalk, gold, silver, and salts of lead to correct the accumulation of malignant acids. One prescription was found to be particularly beneficial. It consisted of crab's eye (1 scruple), red coral (1 scruple), salt of tartar (15 grains), oils of cloves (12 drops), oil of cumin (12 drops), and opium (5 grains). The mixture was fermented to powder and divided for seven doses, and one dose was given per day.

Despite all claimed cures, Motherby's Medical Dictionary,published in 1791, admitted that if a cancer cannot be cured with the knife, the method of treatment with medicinal preparations is only palliative. As a palliative remedy, it was recommended to use a mixture of vinegar and water for ulcerated cancer. If this failed a plaster made of crow's foot, dog-fennel, and arsenic powder should be prepared. The mixture was dried in the sun and after adding the yolk of an egg it was smeared upon a piece of pig's bladder and then laid over the cancer.It was indicated that the plaster drops off of itself in about a week and that repeated applications are often needed because the ingredients only reach as far as into the cellular membrane.

For uterine cancer, particularly at postmenopausal age, Motherby recommended a tar-water, hemlock, and ferrum ammoniacale bath. For cancerous ulcers of the womb he suggested vaginal injections of a decoction of hemlock, arsenic, opium, gentian of roses, and carrot. Adding carrot was important, he wrote, to control bleeding and to remove the nauseous smell that often attends cancerous ulcers. As to internal remedies, muriated quicksilver (mercury), ferrum ammoniacale, chloride of bromide, and tablets of arsenic were suggested. For children with cancer of the eye, three teaspoonfuls of arsenic solution per day was recommended. Finally, he listed a highly recommended prescription of sulphur of zinc, aqueous opium, and extract of conii for lymphatic glands secondarily affected by cancer.

The introduction of pure chemicals as therapeutic agents was extremely slow, as reflected in Récamier's book on treatment of cancer, published in 1829. In over 1200 pages, in 2 volumes, he listed only a few medical remedies: pate of arsenic, nitrate of mercury, and solution of conium. It seems there was a general agreement in the mid-1800s among therapists that long-term application of belladonna plaster and mercurial soap could achieve the long-term cure of scirrhous breast carcinoma. Of all the preparations used as caustics, according to Walsheand Dupuytren, arsenic acid combined with soot and saliva held the most promise. Similar results were obtained by the fumigation of superficial cancers with cinnabar and chloride of zinc. Internally, cod liver, milk, boiled figs, and gray lizard were tried with limited success. Due to inconsistent results, the Medical Committee and the Board of Governors at the Middlesex Hospital in London approved the first clinical trial in the history of medicine to compare the results of internal (medical) and external (surgical) therapies of cancer. The protocol and results were reported by Fell without a convincing conclusion.

Increased interest in chemotherapy of tumors during the second half of the 19th century is a consequence of the demonstration that microorganisms causing infectious diseases can be killed by chemotherapy. Louis Pasteur (1822-1895), Robert Koch (1843-1910), and Joseph Lister (1827-1912) were pioneers in pathobiology and bacteriology as well as in the chemotherapy of infectious diseases. A contemporary of Lister and a disciple of Koch, Paul Ehrlich (1854-1915), while he was a medical student at the age of 24, discovered by using methylene blue that certain parts of the cells absorbed the stain and other parts did not. In 1891, Ehrlich applied his staining methods to the study of blood and bone marrow and was able to distinguish lymphoid and myeloid cells and coined the term of myeloid leukemia. Soon after his work with blood films and intravital stains, Ehrlich discovered the arsenical compound salvarsan to be an effective agent against syphilis and trypanosomiasis. For his work on serum therapy and cellular immunity he shared the Nobel Prize with Metchnikoff in 1908. Ehrlich's application of the old Paracelsian idea of specific remedies for specific diseases led him to the idea that cancerous cells can be damaged by chemicals without harm to the healthy host tissues. At the time Ehrlich received the Nobel Prize, he was deeply involved in the study of immunology and the chemical effect of paramidobenzol, phenylarsenoxyl, diamidoarsenobenzol, and pyocyanase on carcinomas and sarcomas. He summarized his observations in a book of 247 pages that is known to be the first book on chemotherapy

After the outbreak of the First World War all scientific works came to halt in Europe. After the war, the seeds of chemotherapy, which were planted in Europe before the war, began to grown in the United States. In 1921 trypsin and amylopsin were introduced as new treatments for cancer, followed by the discovery in 1925 that the injection of urathan in rabbits and rats decreased circulating lymphocytes. The national interest in the United States of conquering cancer was expressed, in 1937, in the National Cancer Act, passed by the Congress.

An observation made during the First World War that mustard gas poisoning caused leukopenia lead to the introduction in 1942 of nitrogen mustard as a promising agent to treat lymphomas and leukemias. The conclusion that two naturally occurring substances, inositol and folic acid, inhibited the growth of breast cancer in mice induced thinking regarding whether they were suitable for chemotherapy in humans. While these and other chemotherapeutic agents were seriously considered for clinical trials at the conclusion of the Second World War, in 1946, the American Association for Control of Cancer was reorganized as the American Cancer Society. The publication of the Society's own periodical, Cancer, was inaugurated in 1948. In the same year, it was announced that the remission of acute leukemia in children can be achieved with folic acid antagonists.

As a continuation of these efforts, it was realized in the early 1950s that the solution of the cancer problem rested on the discovery of chemical molecules that can reach and destroy the cancer cells in the body. With this realization, the period of a new area in medicine, modern chemotherapy, began. After it was shown in a fast sequence that a pyramidine antagonist is effective in the treatment of myeloblastic leukemia, vinca alkaloids are useful in the treatment of lymphomas and lymphocytic leukemias, and actinomycin-D possesses carcinolytic properties, it was time to announce in 1956 that a human cancer, choriocarcinoma of the uterus, could be cured with methotrexate.